Fig. 8. Kaplan-Meier curve for symptom-free survival in patients with Budd-Chiari syndrome managed by percutaneous recanalization and medical therapy. Symptom-free survival: P < 0.0001, log-rank test (percutaneous recanalization: 1 yr, 93.3%; 5 yr, 81.7%; medical therapy: 1 yr, 26.0%; 5 yr, 0%).

Int J Gastrointest Interv 2019;8:74~81 https://doi.org/10.18528/ijgii180001

© Int J Gastrointest Interv